Keita Shibata

669 total citations
30 papers, 388 citations indexed

About

Keita Shibata is a scholar working on Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Keita Shibata has authored 30 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Keita Shibata's work include Acute Ischemic Stroke Management (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Keita Shibata is often cited by papers focused on Acute Ischemic Stroke Management (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Keita Shibata collaborates with scholars based in Japan, United States and Thailand. Keita Shibata's co-authors include Terumasa Hashimoto, Keiji Hasumi, Koji Nobe, Kazuo Honda, Takuro Miyazaki, Hisayuki Ohata, Akira Miyazaki, Qian Huang, Reiko Ikebe and Mitsuo Ikebe and has published in prestigious journals such as Stroke, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Keita Shibata

27 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keita Shibata Japan 12 90 84 77 57 53 30 388
Netra Joshi United States 7 148 1.6× 79 0.9× 30 0.4× 76 1.3× 38 0.7× 7 366
Chi D. Kim South Korea 12 165 1.8× 51 0.6× 33 0.4× 41 0.7× 21 0.4× 13 492
Tomoko Matsuo Japan 8 253 2.8× 58 0.7× 67 0.9× 62 1.1× 35 0.7× 8 671
Shinsuke Kiritoshi Japan 6 205 2.3× 56 0.7× 61 0.8× 53 0.9× 54 1.0× 6 575
Rossana Ballerio Italy 9 154 1.7× 36 0.4× 25 0.3× 45 0.8× 30 0.6× 10 375
Angana Gupta Rajapakse Switzerland 10 203 2.3× 75 0.9× 81 1.1× 21 0.4× 32 0.6× 11 578
Pavlos Chaitidis Germany 12 197 2.2× 92 1.1× 22 0.3× 95 1.7× 27 0.5× 14 498
Amir Ghorbani Haghjo Iran 12 157 1.7× 26 0.3× 44 0.6× 36 0.6× 25 0.5× 17 532
Vinay Sachdev Austria 15 234 2.6× 88 1.0× 104 1.4× 20 0.4× 20 0.4× 22 542
Belma Korkmaz Türkiye 14 125 1.4× 211 2.5× 30 0.4× 58 1.0× 19 0.4× 27 437

Countries citing papers authored by Keita Shibata

Since Specialization
Citations

This map shows the geographic impact of Keita Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keita Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keita Shibata more than expected).

Fields of papers citing papers by Keita Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keita Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keita Shibata. The network helps show where Keita Shibata may publish in the future.

Co-authorship network of co-authors of Keita Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Keita Shibata. A scholar is included among the top collaborators of Keita Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keita Shibata. Keita Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shibata, Keita, et al.. (2025). Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model. Journal of Diabetes and its Complications. 39(7). 109061–109061.
2.
Aoki, Akira, et al.. (2025). SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosis. Journal of Pharmacological Sciences. 159(1). 25–34.
3.
4.
Shibata, Keita, Michishige Terasaki, Yuta Saito, et al.. (2024). SMTP-44D alleviates diabetic retinopathy by suppressing inflammation and oxidative stress in in vivo and in vitro models. Journal of Pharmacological Sciences. 157(2). 57–64. 1 indexed citations
5.
Yamaguchi, Tomoaki, Keita Shibata, Keiji Hasumi, & Koji Nobe. (2024). Potent Efficacy of 3-Amino-4-hydroxy Benzoic Acid, a Small Molecule Having Anti-fibrotic Activity, in a Mouse Model of Non-alcoholic Steatohepatitis. Biological and Pharmaceutical Bulletin. 47(2). 434–442. 1 indexed citations
6.
Terasaki, Michishige, Keita Shibata, Yusaku Mori, et al.. (2023). SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis. International Journal of Molecular Sciences. 24(7). 6505–6505. 8 indexed citations
7.
Shibata, Keita, Terumasa Hashimoto, Keiji Hasumi, & Koji Nobe. (2021). Potent efficacy of Stachybotrys microspora triprenyl phenol-7, a small molecule having anti-inflammatory and antioxidant activities, in a mouse model of acute kidney injury. European Journal of Pharmacology. 910. 174496–174496. 14 indexed citations
8.
Hashimoto, Terumasa, Keita Shibata, Kazuo Honda, & Koji Nobe. (2021). Acetic acid treatment causes renal inflammation and chronic kidney disease in mice. Journal of Pharmacological Sciences. 146(3). 160–168. 6 indexed citations
9.
Shibata, Keita, et al.. (2020). SMTP‐44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti‐inflammatory activities. Pharmacology Research & Perspectives. 8(6). e00648–e00648. 19 indexed citations
10.
Shibata, Keita, Terumasa Hashimoto, Takuro Miyazaki, Akira Miyazaki, & Koji Nobe. (2019). Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future. Current Pharmaceutical Design. 25(3). 242–250. 26 indexed citations
11.
Shibata, Keita, et al.. (2017). Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey. BMC Research Notes. 10(1). 396–396. 16 indexed citations
12.
Shibata, Keita, Hiroyasu Sakai, Qian Huang, et al.. (2014). Rac1 Regulates Myosin II Phosphorylation Through Regulation of Myosin Light Chain Phosphatase. Journal of Cellular Physiology. 230(6). 1352–1364. 28 indexed citations
13.
14.
Liu, Elaine, et al.. (2012). Lipopolysaccharide-induced hypothermia and hypotension are associated with inflammatory signaling that is triggered outside the brain. Brain Behavior and Immunity. 28. 188–195. 23 indexed citations
15.
Miyazaki, Takuro, Hisayuki Ohata, Terumasa Hashimoto, et al.. (2011). Distinct Effects of Tissue-Type Plasminogen Activator and SMTP-7 on Cerebrovascular Inflammation Following Thrombolytic Reperfusion. Stroke. 42(4). 1097–1104. 50 indexed citations
16.
Shibata, Keita, Terumasa Hashimoto, Koji Nobe, Keiji Hasumi, & Kazuo Honda. (2011). Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(1). 103–108. 30 indexed citations
17.
Shibata, Keita, Takuro Miyazaki, Hisayuki Ohata, & Kazuo Honda. (2011). Shear Stress–dependent Effects of Lysophosphatidic Acid on Agonist-induced Vasomotor Responses in Rat Mesenteric Artery. Journal of Cardiovascular Pharmacology. 57(5). 604–610. 4 indexed citations
18.
Hashimoto, Terumasa, Hisayuki Ohata, Takuro Miyazaki, et al.. (2011). Spatiotemporal dynamics of intracellular calcium in the middle cerebral artery isolated from stroke‐prone spontaneously hypertensive rats. Experimental Physiology. 97(2). 265–276. 1 indexed citations
19.
Hashimoto, Terumasa, Keita Shibata, Koji Nobe, Keiji Hasumi, & Kazuo Honda. (2010). A Novel Embolic Model of Cerebral Infarction and Evaluation of Stachybotrys microspora Triprenyl Phenol-7 (SMTP-7), a Novel Fungal Triprenyl Phenol Metabolite. Journal of Pharmacological Sciences. 114(1). 41–49. 44 indexed citations
20.
Shibata, Keita, Terumasa Hashimoto, Koji Nobe, Keiji Hasumi, & Kazuo Honda. (2010). A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 382(3). 245–253. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Netra Joshi Breakdown of academic impact, for papers by Chi D. Kim Breakdown of academic impact, for papers by Tomoko Matsuo Breakdown of academic impact, for papers by Shinsuke Kiritoshi Breakdown of academic impact, for papers by Rossana Ballerio Breakdown of academic impact, for papers by Angana Gupta Rajapakse Breakdown of academic impact, for papers by Pavlos Chaitidis Breakdown of academic impact, for papers by Amir Ghorbani Haghjo Breakdown of academic impact, for papers by Vinay Sachdev Breakdown of academic impact, for papers by Belma Korkmaz
Rankless by CCL
2026